MedPath

Dusa Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:9

Trial Phases

2 Phases

Phase 2:8
Phase 3:2

Drug Approvals

1

FDA:1

Drug Approvals

LEVULAN KERASTICK

Approval Date
Feb 20, 2020
FDA

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 2
8 (80.0%)
Phase 3
2 (20.0%)

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Phase 3
Withdrawn
Conditions
Actinic Keratosis
Interventions
Drug: Vehicle
Device: IBL 20 mW
Device: IBL 10 mW
First Posted Date
2017-01-18
Last Posted Date
2017-11-07
Lead Sponsor
DUSA Pharmaceuticals, Inc.
Registration Number
NCT03024060
Locations
🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

Altman Dermatology Associates, Arlington Heights, Illinois, United States

🇺🇸

Shideler Clinical Research Center, Carmel, Indiana, United States

and more 4 locations

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

Phase 2
Completed
Conditions
Actinic Keratosis
Interventions
Drug: Topical Solution Vehicle
Device: IBL 10 mW
Device: IBL 20 mW
Procedure: Microneedle lesion preparation
First Posted Date
2015-12-16
Last Posted Date
2018-01-18
Lead Sponsor
DUSA Pharmaceuticals, Inc.
Target Recruit Count
137
Registration Number
NCT02632110
Locations
🇺🇸

UCSD Dermatology, San Diego, California, United States

🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

MOORE Clinical Research, Inc, Brandon, Florida, United States

and more 5 locations

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

Phase 2
Completed
Conditions
Keratosis, Actinic
Interventions
Drug: Aminolevulinic Acid (ALA)
Device: BLU-U
First Posted Date
2015-12-11
Last Posted Date
2017-09-18
Lead Sponsor
DUSA Pharmaceuticals, Inc.
Target Recruit Count
14
Registration Number
NCT02628236
Locations
🇺🇸

DermResearch, Inc., Austin, Texas, United States

🇺🇸

J&J Studies, Inc, College Station, Texas, United States

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

Phase 2
Completed
Conditions
Keratosis, Actinic
Interventions
Drug: Aminolevulinic Acid (ALA)
Device: BLU-U
First Posted Date
2014-11-02
Last Posted Date
2017-01-13
Lead Sponsor
DUSA Pharmaceuticals, Inc.
Target Recruit Count
29
Registration Number
NCT02281136
Locations
🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

Shideler Clinical Research Center, Carmel, Indiana, United States

🇺🇸

DermResearch, Inc., Austin, Texas, United States

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Phase 2
Completed
Conditions
Actinic Keratosis
Interventions
Drug: Topical Solution Vehicle
Device: BLU-U
Procedure: Cryotherapy
First Posted Date
2014-09-15
Last Posted Date
2018-08-24
Lead Sponsor
DUSA Pharmaceuticals, Inc.
Target Recruit Count
166
Registration Number
NCT02239679
Locations
🇺🇸

UCSD Dermatology, San Diego, California, United States

🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

Altman Dermatology Associates, Arlington Heights, Illinois, United States

and more 5 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.